We conduct comprehensive investigations on domestic suppliers in China through direct communication and on-site visits, collecting and screening high-quality supplier information. We also perform on-site inspections of manufacturing plants, covering critical areas such as GMP compliance, production site management, and quality systems, to ensure the reliability and qualifications of our cooperative partners.

For export business to Japan, we provide one-stop service of regulatory compliance support, including: MF registration services in Japan, Foreign Manufacturer Accreditation agency services, GMP guidance and improvement consulting for manufacturing sites, assisting clients in smoothly navigating access pathways into Japanese market.

Whether for client-conducted factory audits or official inspections by Japan's PMDA (Pharmaceuticals and Medical Devices Agency), we can offer end-to-end coordination and on-site accompaniment service to ensure that the audit process is efficient, compliant, and transparent.

Leveraging our years of established procurement networks in the pharmaceutical sector, we flexibly utilize our supplier support capabilities to secure stable product supply. Additionally, we can assist in introducing collaborative R&D partners, helping clients build a trustworthy, full-chain system from R&D to mass production.

The Company has also begun to strategically position itself in the licensing business for promising new drug candidate compounds and formulations in both China and the United States. Our business scope covers a wide range of therapeutic areas, including tumor immuno-cell therapy, cardiovascular diseases, rare diseases, neurological disorders, ophthalmology, and more. By fully mobilizing resources across our offices in China, the United States, and Japan, we introduce high-potential products from these three regions to pharmaceutical companies worldwide.